Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Researchers Find Key to Blood-Clotting Process

Published: Wednesday, June 26, 2013
Last Updated: Wednesday, June 26, 2013
Bookmark and Share
Researchers have uncovered a key process in understanding how blood clots form that could help pave the way for new therapies to reduce the risk of heart attacks.

The research, carried out in collaboration with researchers from the Universities of Homburg and Heidelberg in Germany, the National Institutes of Health in the USA and University College London, focuses on the action of platelets in the blood clotting process.

These platelets are very small cells in our blood that are essential to blood clotting when we damage a blood vessel. Unfortunately, platelet clots can also block blood vessels in the heart, leading to heart attacks.

When blood vessels are damaged they expose the protein collagen and produce thrombin, which then trigger the platelets to create a clot or thrombus.  It has been known for some time that platelets are activated much more strongly if they detect both collagen and thrombin at the same time, but until now it has been a puzzle as how this happens.

Now the research from Bristol and others, which is published today [25 June] in the journal Science Signalling, has shown that platelets respond to simultaneous exposure to these two strong signals by opening a channel in their outer membrane, made up of the proteins TRPC3 and TRPC6.

This channel, which is not opened if platelets detect only one of the damage signals, allows calcium ions to penetrate the platelets and that triggers the platelets to expose a procoagulant surface, which means that they generate more thrombin. This can lead to a vicious cycle of more platelet activation, the generation of more thrombin and bigger clots.

Bristol’s contribution to this research project has been supported by the British Heart Foundation and it’s hoped in the future it could help guide the development of new therapies to control dangerous blood clotting.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Human Trials of Manufactured Blood Within Two Years
The first human trials of lab-produced blood to help create better-matched blood for patients with complex blood conditions has been announced by NHS Blood and Transplant.
Monday, June 29, 2015
Scientific News
Genetic Variability in Cell Bank Lots
Researchers working with cancer cells from the same cell bank acquired at the same time, found that the cells were genetically different.
Rapidly Generating Bone, Heart Muscle
A new study shows that combining positive and negative signals can quickly and efficiently steer stem cells down complex developmental pathways to become specialized tissues that could be used in the clinic.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer.
New Mechanism of Tuberculosis Infection
Researchers have identified a new infection mechanism of tuberculosis that could lead to a new therapeutic angle.
Modelling ALS Requires ‘Aged’ Stem Cells
Research suggests engineered cells are too ‘young’ to accurately model ALS and should be 'aged' to speed progress toward finding potential treatments.
Protein Reinforces Growth of Damaged Muscles
Biologists have found a protein involved in stem cells that bolsters damaged muscle tissue growth - potential for muscle degeneration treatments.
Treating HIV with Cancer-Fighting Gene Shows Promise
A type of gene immunotherapy that has shown promising results against cancer could also be used against HIV.
'Antigen-Presenting Cell' Defends Against Cancer
Through advanced imaging, researchers have identified cells that encourages increases in immune system cancer defences.
HIV Hides No Longer
Researchers are working to create proteins that clear HIV-infected cells in order to eliminate latent infection and dormancy.
R&D Agreement for Development of CtDNA Diagnostics
SeraCare and NIST partner for development of ctDNA diagnostic assay reference materials.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!